The company plans to use proceeds to repurchase common stock and for general corporate purposes, including the repayment of outstanding commercial paper borrowings and upcoming debt maturities

Common stock in Fibrocell Science Inc., of Exton, Pa., has been approved for listing on the NYSE Market, to commence trading on May 17, under the ticker symbol FCSC

Kinnovata plans to develop, manufacture and commercialize respiratory products for China and other regional Asian markets, initially exploiting Vectura's Clickhaler and Duohaler dry powder inhaler (DPI) technology platforms in asthma and chronic obstructive pulmonary disease...KingYork is expected to hold a 50 percent equity share, with Vectura holding 35 percent and Zendex and partners holding 15 percent

The split is intended to increase the per-share trading price of the common stock to satisfy the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market

turned its attention to other candidates in its pipeline...The Carlsbad, Calif.-based company priced an underwritten public offering of 9 million shares of its common stock at $19 per share, seeking to raise $171 million from the offering, which is expected to close on or about May 14...continue to view shares as undervalued based on the >$1B potential of ISIS-SMN-Rx, as well as the promise of ISIS-TTR-Rx and Isis' 20+ other pipeline candidates," he wrote

He allegedly permitted a trader, dubbed John Doe in the affidavit, to purchase 20,000 shares of an initial public offering of stock for GeneMedicine Inc., of The Woodlands, Texas, in exchange for which John Doe agreed to purchase 5,000 shares of stock issued by two other companies, Hemisphere and Ecogen Inc...Public Information Officer Marvin Smilon, of the U.S. Attorney's Office, told BioWorld Today that a hearing is set for May 14 before Judge Kevin Thomas Duffy, in Manhattan District Court

StemCells issued SVB a warrant to purchase 293,531 shares of common stock at $1.7034 per share 4/10/13 Unigene Laboratories Inc. (Boonton, N.J.) Amended financing agreement N/A $0.75 Unigene entered a second amendment to a financing agreement with affiliates of Victory Park Capital Advisors LLC, whereby VPC agreed to purchase an additional $750,000 senior secured note convertible into shares of Unigene common stock 4/9/13 VistaGen Therapeutics Inc. (South San Francisco) Investment 72S $36

The company expects to repurchase about $7.5 billion of common stock over the next 12 months, financed through a combination of debt issuance and operating cash flows, with the remainder to be repurchased over time with no time limit

Soligenix also will issue 1 million shares of its common stock to Intrexon, representing 8.5 percent of its outstanding shares, and provide Intrexon with the right to participate in future offerings and to purchase the company's shares in the open market

26, 2017, at an interest rate of 13 percent, and the conversion rate will be re-priced from $3.78 to $1.25 per share of common stock...Due to third-party manufacturing issues, distribution of Janssen Products LP's Caelyx in Europe has been intermittently disrupted since 2011

BioMarin Pharmaceutical Inc., of San Rafael, Calif., said it submitted a marketing authorization application to the European Medicines Agency for Vimizim (BMN-110, elosulfase alfa), an enzyme replacement therapy for patients with rare lysosomal storage disorder mucopolysaccharidosis Type IVA, also called Morquio A syndrome...OvaScience, of Cambridge, Mass, said its common stock was approved for listing on Nasdaq under the ticker "OVAS" and will start trading April 30

flutemetamol to help select patients for a Phase I trial testing Eisai's E2609, a BACE inhibitor for the potential treatment of Alzheimer's disease...The Antimonopoly Committee of Ukraine gave approval to Valeant Pharmaceuticals International Inc., of Laval, Quebec, for its proposed acquisition of Obagi Medical Products Inc., of Long Beach, Calif...AMC approval is one of the conditions for consummation of its tender offer for all outstanding shares of common stock in Obagi at $24 per share

Addex Therapeutics, of Geneva, said regulatory authorities in the Netherlands gave approval to start in the first half of this year a Phase I study of ADX71441, a GABA-B receptor positive allosteric modulator, for Charcot-Marie-Tooth1A (CMT1A) neuropathy and other disease indications...Those and other data were presented at the European Association for the Study of the Liver meeting in Amsterdam, the Netherlands...Based upon the number of shares of Tranzyme common stock to be issued in the merger

Amgen indicated that demand trends have not changed," wrote analyst Eric Schmidt, of New York-based Cowen and Co., in a research note, "but that much of the sequential decline in sales was due to late 2012 buy-ins by secondary customers ahead of Q1 price increases...Amgen's other product sales compared with Q1 2012: Neulasta and Neupogen earned $1 .34 billion (flat), Vectibix earned $87 million (down 3 percent), Nplate earned $96 million (up 7 percent) and Xgeva – reflecting an increased segment

To date, Celltrion and Hospira have identified only two products from the alliance – Remsima, a biosimilar version of autoimmune drug Remicade (infliximab, Johnson & Johnson), which won approval as the first biosimilar monoclonal antibody last year in Korea, and a biosimilar version of breast cancer drug Herceptin (trastuzumab, Roche). (See BioWorld Today, April 19, 2013...Zalicus Inc., of Cambridge, Mass., received notification from Nasdaq that the company's application to list its common stock on

The company is also reducing the number of shares of common stock from 1,5000,000,000 to 100,000,000...According to Epivax Inc., of Providence, R.I., the new H7N9 flu virus has serious potential for rapid expansion on a global scale...To date, 60 people have been confirmed infected with H7N9 in China, with 13 deaths

Subject to shareholder approval, at closing NovaDel will receive $400,000 in cash, 50 million shares of Suda common stock and 10 million options to purchase Suda common shares at 5 cents per share

Anacor also will create an expanded library of boron compounds to screen for additional potential drug candidates to treat neglected diseases and will provide access to the expanded library to the Gates Foundation and others, including academic, governmental and other nonprofit institutions or equivalent entities...The spinout is intended to split the clinical RVX-208 program from the epigenetics platform to create distinct corporate environments so Resverlogix is structurally ready for acquisition

Maturation inhibitors are designed to block virus replication by interfering with the formation of infectious HIV virus...Captisol, a chemically modified cyclodextrin, is used to improve the solubility and stability of drugs and currently is incorporated in six marketed products...SionX is designed to enable high-density expression of recombinant human ion channels on the cell membranes of Tetrahymena thermophile